-
2023-509492-16-00
4
2021-03-30
Adult participants with metastatic (advanced) solid tumors.
-
2024-514025-30-00
4
2021-03-25
Ocular conservative treatment for retinoblastoma
-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2024-515019-22-00
5
2021-02-26
Septic shock
-
2022-502642-27-00
9
2020-11-26
RElapse in previously irradiated Prostate bed
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2024-513248-27-00
5
2020-07-20
Patients, men or women over 18 old, with inoperable vertebral bone met
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-515584-56-00
5
2020-06-19
Cutibacterium acnes infection in shoulder arthroplasty with males
-
2024-514603-34-00
5
2020-03-02
intermediate-risk differentiated thyroid cancer patients
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2023-508926-91-00
5
2019-12-05
Stage IV childhood renal tumour with pulmonary +/- non-pulmonary
metas
-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2023-508072-11-00
5
2019-06-26
Castration-resistant prostate cancer
-
2023-508302-24-00
4
2019-05-07
Locally Advanced/Metastatic Urothelial Cancer
-
2024-514094-22-00
5
2019-01-18
Intrecerebral Haemorrhage
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-518578-15-00
5
2018-02-05
Is to demonstrate a non inferior efficacy of azithromycin and so the p
-
2024-515678-29-00
4
2016-11-15
Patients with metastatic tumours (colorectal, non-small cell lung, ren
-
2024-516704-41-00
11
2016-03-30
Rheumatoid Arthritis
-
2024-516103-16-00
4
2015-12-04
Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi